This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Arena Pharmaceuticals Inc (ARNA)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 221.88M 156.09M 57.63M 150.67M
Receivables 10.60M 5.56M 607.00K 3.50M
Inventories 12.76M 6.06M 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 248.81M 171.16M 60.26M 156.81M
Property, Plant & Equipment, Gross 165.37M 159.33M 157.33M 158.25M
Accumulated Depreciation & Depletion 87.98M 83.92M 75.26M 66.72M
Property, Plant & Equipment, Net 77.39M 75.42M 82.07M 91.53M
Intangibles 10.18M 10.61M 11.03M 12.03M
Other Non-Current Assets 3.43M 4.02M 3.77M 5.99M
Total Non-Current Assets 91.00M 90.05M 96.87M 109.56M
Liabilities & Shareholder Equity
Total Assets 339.81M 261.21M 157.13M 266.36M
Accounts Payable 23.03M 3.88M 2.36M 5.02M
Short Term Debt 2.06M 1.66M 1.31M 18.78M
Other Current Liabilities 567.00K 3.07M 0.00 0.00
Total Current Liabilities 70.74M 29.91M 14.36M 36.87M
Long Term Debt 0.00 0.00 14.70M 27.40M
Deferred Income Taxes 247.00K 122.00K 0.00 0.00
Other Non-Current Liabilities 106.22M 59.74M 43.05M 46.31M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 177.21M 132.65M 132.21M 149.48M
Total Liabilities 247.95M 162.57M 146.57M 186.35M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 91.86M 98.64M 10.56M 80.02M
Common Par 22.00K 22.00K 15.00K 12.00K
Additional Paid In Capital 1.29B 1.28B 1.11B 1.09B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -1.21B -1.19B -1.08B -989.12M
Treasury Stock 0.00 0.00 -23.07M -23.07M
Other Equity Adjustments 5.73M 5.49M 4.74M 4.97M
Total Capitalization 91.86M 98.64M 25.26M 107.42M
Total Equity 91.86M 98.64M 10.56M 80.02M
Total Liabilities & Stock Equity 339.81M 261.21M 157.13M 266.36M
Total Common Shares Outstanding 218.82M 217.48M 146.09M 121.52M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 3.00M 3.00M
Basic Weighted Shares Outstanding 218.10M 196.52M 139.17M 109.57M
Diluted Weighted Shares Outstanding 218.10M 196.52M 139.17M 109.57M
Number of Employees 310 293 266 351
Number of Part-Time Employees 0 0 0 0
ARNA News

ARNA Arena Pharmaceuticals Inc

Analysts Ratings for ARNA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 3 3 2 3
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
GET ARNA ANALYST REPORT

Brokerage Partners

ARNA Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs